Haseeb Ahsan

Prof. Dr. Haseeb Ahsan


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Journal of Carcinogenesis
Verified
Journal Article
Open access
PDF file
GWGulam Waris
Gulam Waris
HAHaseeb Ahsan
Haseeb Ahsan
J Carcinog, Official publication of Carcenogenesis Press

6 January 2011 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
Mohammad OlaMohammad Ola
Mohammad Ola
MOHD NAWAZMOHD NAWAZ
MOHD NAWAZ
HAHaseeb Ahsan
Haseeb Ahsan

25 January 2015 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
WSWaseem Ahmad Siddiqui
Waseem Ahmad Siddiqui
AAAmjid Ahad
Amjid Ahad
HAHaseeb Ahsan
Haseeb Ahsan

20 January 2020 in Journal of Food Biochemistry
Verified
Journal Article
Closed access
PDF file
SASyed Saqib Ali
Syed Saqib Ali
HAHaseeb Ahsan
Haseeb Ahsan
MZMohammad Khalid Zia
Mohammad Khalid Zia
TSTooba Siddiqui
Tooba Siddiqui
FKFahim Halim Khan
Fahim Halim Khan

31 May 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AAAnas Ahmad
Anas Ahmad
MIMohammad Imran
Mohammad Imran
HAHaseeb Ahsan
Haseeb Ahsan
A biomarker is any measurable biological moiety that can be assessed and measured as a potential index of either normal or abnormal pathophysiology or pharmacological responses to some treatment regimen. Every tissue in the body has a distinct biomolecular make-up, which is known as its biomarkers, which possess particular features, viz., the levels or activities (the ability of a gene or protein to carry out a particular body function) of a gene, protein, or other biomolecules. A biomarker refers to some feature that can be objectively quantified by various biochemical samples and evaluates the exposure of an organism to normal or pathological procedures or their response to some drug interventions. An in-depth and comprehensive realization of the significance of these biomarkers becomes quite important for the efficient diagnosis of diseases and for providing the appropriate directions in case of multiple drug choices being presently available, which can benefit any patient. Presently, advancements in omics technologies have opened up new possibilities to obtain novel biomarkers of different types, employing genomic strategies, epigenetics, metabolomics, transcriptomics, lipid-based analysis, protein studies, etc. Particular biomarkers for specific diseases, their prognostic capabilities, and responses to therapeutic paradigms have been applied for screening of various normal healthy, as well as diseased, tissue or serum samples, and act as appreciable tools in pharmacology and therapeutics, etc. In this review, we have summarized various biomarker types, their classification, and monitoring and detection methods and strategies. Various analytical techniques and approaches of biomarkers have also been described along with various clinically applicable biomarker sensing techniques which have been developed in the recent past. A section has also been dedicated to the latest trends in the formulation and designing of nanotechnology-based biomarker sensing and detection developments in this field.

18 April 2013 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
ARAhmed A. Rehman
Ahmed A. Rehman
HAHaseeb Ahsan
Haseeb Ahsan
FKFahim H. Khan
Fahim H. Khan